Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.6, replacing v3.6.5, indicating a maintenance release of the site. It reflects an update to the site's version tag rather than any changes to study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T19:33:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.5, replacing the previous v3.6.4. This reflects a minor backend/version update and does not change the study information or how the page is used.
    Difference
    0.0%
    Check dated 2026-08-11T18:36:02.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Site revision updated from v3.6.3 to v3.6.4, signaling a platform update rather than any modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-21T12:36:17.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Publications section added with a PubMed-derived citation and a note about automatic population from PubMed. The change provides direct literature references and clarifies data provenance for the study record.
    Difference
    0.2%
    Check dated 2026-07-14T08:51:22.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3. This is a minor version update and does not affect the study content or page functionality.
    Difference
    0.0%
    Check dated 2026-07-07T01:01:34.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.0 to v3.6.2, indicating a maintenance update to the ClinicalTrials.gov entry. This change does not modify study content or results.
    Difference
    0.0%
    Check dated 2026-06-29T18:47:06.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.